Search title Research
Clinical Trials
A Phase 1 Study of RGX-104, a Small Molecule LXR Agonist, With or Without Nivolumab in Patients With Advanced Solid Malignancies and Lymphoma With an Expansion in Select Malignancies
STATUS: Active, Recruiting
A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511])
STATUS: Active, Recruiting
A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab Versus Placebo in Subjects With High Risk Invasive Urothelial Carcinoma
STATUS: Active, Recruiting
A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab With or Without Platinum-Based Combination Chemotherapy vs Chemotherapy in Subjects With Advanced or Metastatic Urothelial Carcinoma
STATUS: Active, Recruiting
Molecular Analysis for Therapy Choice (MATCH)
STATUS: Active, Recruiting